Literature DB >> 20841898

Designing a concept for an IT-infrastructure for an integrated research and treatment center.

Sebastian Stäubert1, Alfred Winter, Ronald Speer, Markus Löffler.   

Abstract

Healthcare and medical research in Germany are heading to more interconnected systems. New initiatives are funded by the German government to encourage the development of Integrated Research and Treatment Centers (IFB). Within an IFB new organizational structures and infrastructures for interdisciplinary, translational and trans-sectoral working relationship between existing rigid separated sectors are intended and needed. This paper describes how an IT-infrastructure of an IFB could look like, what major challenges have to be solved and what methods can be used to plan such a complex IT-infrastructure in the field of healthcare. By means of project management, system analyses, process models, 3LGM<sup>2</sup>-models and resource plans an appropriate concept with different views is created. This concept supports the information management in its enterprise architecture planning activities and implies a first step of implementing a connected healthcare and medical research platform.

Mesh:

Year:  2010        PMID: 20841898

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  1 in total

1.  Smart Medical Information Technology for Healthcare (SMITH).

Authors:  Alfred Winter; Sebastian Stäubert; Danny Ammon; Stephan Aiche; Oya Beyan; Verena Bischoff; Philipp Daumke; Stefan Decker; Gert Funkat; Jan E Gewehr; Armin de Greiff; Silke Haferkamp; Udo Hahn; Andreas Henkel; Toralf Kirsten; Thomas Klöss; Jörg Lippert; Matthias Löbe; Volker Lowitsch; Oliver Maassen; Jens Maschmann; Sven Meister; Rafael Mikolajczyk; Matthias Nüchter; Mathias W Pletz; Erhard Rahm; Morris Riedel; Kutaiba Saleh; Andreas Schuppert; Stefan Smers; André Stollenwerk; Stefan Uhlig; Thomas Wendt; Sven Zenker; Wolfgang Fleig; Gernot Marx; André Scherag; Markus Löffler
Journal:  Methods Inf Med       Date:  2018-07-17       Impact factor: 2.176

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.